Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies (Q80387253)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Krishna V Komanduri

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

11

Shpall EJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

Saliba RM

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

3

Champlin RE

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

5

Giralt SA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

7

Khouri IF

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Ozdemir E

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Couriel DR

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

de Lima M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kornblau SM

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Anderlini P

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Qazilbash MH

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Molldrem JJ

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Chemaly RF

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

28 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

125-136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530009%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705699

31 December 2019

exact match

0 references

cites work

Recent advances in the therapy and prevention of CMV infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

CMV antigenemia following bone marrow transplantation: risk factors and outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705699

7 January 2021